Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 350 of 2051 entries
View as:

Study of Pembrolizumab (MK-3475) in Participants With Advanced Non-small Cell Lung Cancer (MK-3475-025/KEYNOTE-025)

Phase: N/A Priority: Normal
NCT ID: NCT02007070 Org: User:
Start: 02/28/14 End: 03/31/17 Due: 03/31/18

Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)

Phase: N/A Priority: Normal
NCT ID: NCT00705224 Org: User:
Start: 05/31/08 End: 08/31/10 Due: 08/31/11

Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002)

Phase: N/A Priority: Normal
NCT ID: NCT01254604 Org: User:
Start: 12/01/11 End: 05/09/13 Due: 05/09/14

A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00757939 Org: User:
Start: 09/30/08 End: 10/31/10 Due: 10/31/11

Safety and Pharmacokinetics of MK-7680 in Participants With Hepatitis C (MK-7680-003)

Phase: N/A Priority: Normal
NCT ID: NCT02269059 Org: User:
Start: 12/31/14 End: 04/30/15 Due: 04/30/16

A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248)

Phase: N/A Priority: Normal
NCT ID: NCT00779584 Org: User:
Start: 10/17/08 End: 05/28/11 Due: 05/28/12

A Study in Subjects With Perennial Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00210015 Org: User:
Start: 12/31/02 End: 04/30/03 Due: 04/30/04

Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)

Phase: N/A Priority: Normal
NCT ID: NCT03239873 Org: User:
Start: 10/17/17 End: 04/02/19 Due: 04/02/20

Pharmacokinetics of Peginterferon Alfa-2b in Participants With Moderate and Severe Renal Impairment (P05655)

Phase: N/A Priority: Normal
NCT ID: NCT01432535 Org: User:
Start: 11/30/11 End: 08/31/12 Due: 08/31/13

Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)

Phase: N/A Priority: Normal
NCT ID: NCT00885352 Org: User:
Start: 04/15/09 End: 11/10/10 Due: 11/10/11

Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Phase: N/A Priority: Normal
NCT ID: NCT01294735 Org: User:
Start: 02/28/11 End: 05/31/12 Due: 05/31/13

A 52-Week Study to Assess the Effects of MK0822 on Knee Osteoarthritis (MK-0822-011)

Phase: N/A Priority: Normal
NCT ID: NCT00397683 Org: User:
Start: 10/31/06 End: 04/30/07 Due: 04/30/08

A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)

Phase: N/A Priority: Normal
NCT ID: NCT01217073 Org: User:
Start: 10/08/10 End: 04/01/13 Due: 04/01/14

A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)

Phase: N/A Priority: Normal
NCT ID: NCT02532855 Org: User:
Start: 10/20/15 End: 10/10/17 Due: 10/10/18

Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)

Phase: N/A Priority: Normal
NCT ID: NCT00604968 Org: User:
Start: 02/07/07 End: 10/16/09 Due: 10/16/10

Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)

Phase: N/A Priority: Normal
NCT ID: NCT00442936 Org: User:
Start: 02/15/07 End: 10/02/07 Due: 10/02/08

Study of Quavonlimab (MK-1308) in Combination With Pembrolizumab (MK-3475) in Advanced Solid Tumors (MK-1308-001)

Phase: N/A Priority: Normal
NCT ID: NCT03179436 Org: User:
Start: 07/02/17 End: 04/08/24 Due: 04/08/25

Infliximab in High Need Versus Low Need Psoriasis Patients: The IHELP Study (Study P04320)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00254982 Org: User:
Start: 08/31/05 End: 09/30/06 Due: 09/30/07

Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)

Phase: N/A Priority: Normal
NCT ID: NCT01569152 Org: User:
Start: 05/22/12 End: 10/03/13 Due: 10/03/14

Safety and Immunogenicity of V116 in Pneumococcal Vaccine-naïve Adults 50 Years of Age or Older (V116-010, STRIDE-10)

Phase: N/A Priority: Normal
NCT ID: NCT05569954 Org: User:
Start: 11/07/22 End: 02/07/25 Due: 02/07/26

A Study to Evaluate the Use of a Graded Infusion of Intravenous Glucose in the Assessment of Insulin Secretion Rates (MK-0000-078)

Phase: N/A Priority: Normal
NCT ID: NCT01021462 Org: User:
Start: 08/31/07 End: 09/30/07 Due: 09/30/08

Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00687544 Org: User:
Start: 12/31/05 End: 09/30/08 Due: 09/30/09

A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004)

Phase: N/A Priority: Normal
NCT ID: NCT01500382 Org: User:
Start: 02/27/12 End: 01/02/13 Due: 01/02/14

ZOSTAVAX™ Safety Study in Subjects ≥ 60 Years of Age (V211-020)

Phase: N/A Priority: Normal
NCT ID: NCT00550745 Org: User:
Start: 09/30/07 End: 01/31/09 Due: 01/31/10

A Clinical Study of MK-4482 in Chinese Healthy Male Participants (MK-4482-009)

Phase: N/A Priority: Normal
NCT ID: NCT06816030 Org: User:
Start: 06/28/23 End: 08/05/23 Due: 08/05/24